Public access defibrillators
This article was originally published in The Gray Sheet
HR 3462, the Community Access to Emergency Defibrillation Act of 2001 (Community AED Act) is introduced in the House Dec. 12 by Reps. Lois Capps (D-Calif.) and John Shimkus (R-Ill.). The bill authorizes more than $55 mil. a year for five years for communities to purchase automatic external defibrillators and to establish public access to defibrillation (PAD) programs. The measure is identical to S 1275, which was introduced July 31 by Sens. Edward Kennedy (D-Mass.) and Bill Frist (R-Tenn.). Staffers are cautiously optimistic that the bill could be hotlined for floor consideration in the next few weeks. AED manufacturer Medtronic VP-Corporate Controller Gary Ellis notes that its LifePak system direct-to-consumer advertising has helped to build awareness of the condition and its risk factors...
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.